{"protocolSection":{"identificationModule":{"nctId":"NCT06475521","orgStudyIdInfo":{"id":"SBB22R&56319"},"organization":{"fullName":"Nutricia Research","class":"INDUSTRY"},"briefTitle":"A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and follow-on Formula for Healthy Term Infants.","officialTitle":"A Randomised, Controlled, Double-blinded, Multi-country, Multi-centre Trial to Study Growth and Health Outcomes of a New Infant- and follow-on Formula for Healthy Term Infants.","acronym":"GAIA"},"statusModule":{"statusVerifiedDate":"2024-06","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-06-30","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2027-06-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2027-12-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2024-06-21","studyFirstSubmitQcDate":"2024-06-21","studyFirstPostDateStruct":{"date":"2024-06-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2024-06-21","lastUpdatePostDateStruct":{"date":"2024-06-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Nutricia Research","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"To demonstrate growth equivalence of a Baby formula Test Product when compared to the Control product after 16 weeks. And to demonstrate better neurocognitive development at 52 weeks post-baseline in subjects receiving the Test Product, compared to subjects receiving the Control Product. Also, other anthropometric parameters will be investigated up to 52 weeks.\n\nA Breastfed reference group, exclusively breastfed for at least 16 weeks, will also be included."},"conditionsModule":{"conditions":["Baby Formula, Growth Equivalence, Neurocognitive Development, Healthy Infants"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Randomised, controlled, double-blinded, multi-country, multi-center\n\nIncluding Breastfed reference group","primaryPurpose":"BASIC_SCIENCE","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":579,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Arm 1","type":"EXPERIMENTAL","description":"Infant formula test group; Group that receives the test product.","interventionNames":["Other: Infant Formula"]},{"label":"Arm 2","type":"ACTIVE_COMPARATOR","description":"Infant formula control group; Group that receives a comparative control product.","interventionNames":["Other: Infant Formula"]}],"interventions":[{"type":"OTHER","name":"Infant Formula","description":"Test group","armGroupLabels":["Arm 1","Arm 2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Weight gain","description":"To demonstrate equivalence in mean weight gain per day from baseline to 16 weeks post-baseline in subjects receiving the Test product, compared to subjects receiving the Control product","timeFrame":"Baseline to 16 weeks post-baseline"}],"secondaryOutcomes":[{"measure":"Neurocognitive Development","description":"Demonstrate better neurocognitive development as measured by the Bayley Scales of Infant and Toddler Development (Bayley-3) cognitive composite score at 52 weeks post-baseline in subjects receiving the Test product, compared to subjects receiving the Control product.","timeFrame":"52 weeks post baseline"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Healthy, singleton, term born infants (gestational age ≥ 37 weeks + 0 days and ≤ 41 weeks + 6 days).\n* Infants aged ≤ 14 days at enrolment.\n* Weight at birth within 10th to 90th percentile per gestational age and sex, according to Intergrowth Standards\n* For formula feeding groups: Infants fully formula fed at the time of enrolment.\n* For breastfed reference group: Infants exclusively breastfed at the time of enrolment and parent(s) intend to exclusively breastfeed the infant at least until 16 weeks after Visit 1.\n* Written informed consent (IC) from parent(s) and/or legally acceptable representative(s) aged ≥18 years at enrolment.\n\nExclusion Criteria:\n\n* . Infants who require a special diet other than IF with intact cow's milk protein.\n* Infants known or suspected to have cow's milk, fish, and/or soy allergy and/or lactose intolerance.\n* Infants with current or previous illnesses/conditions and/or known or suspected congenital diseases or malformations which could interfere with the study outcomes, as per investigator's clinical judgement.\n* Infants whose mother is known to suffer from an illness or condition which could interfere with the study outcomes, as per investigator's clinical judgement.\n* Infants with previous, current, or intended participation in any concomitant clinical study involving investigational or marketed products.\n* Investigator's uncertainty about the willingness or ability of parents or legally acceptable representative(s) to comply with the protocol requirements.","healthyVolunteers":true,"sex":"ALL","minimumAge":"0 Days","maximumAge":"14 Days","stdAges":["CHILD"]},"contactsLocationsModule":{"centralContacts":[{"name":"Danone Nutricia Research","role":"CONTACT","phone":"0302095000","email":"register.clinicalresearchnutricia@danone.com"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-07-01"}},"hasResults":false}